Auguston kicked off an animated session titled “The People Factor” by outlining all the ways in which the CEO role in ...

Partnership includes the development of combination products, including a fixed-dose combination of petrelintide and Roche’s dual GLP-1/GIP receptor agonist, CT-388, for weight management.

Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.

EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship ...

Lunit announced the results of a prospective study that looked into the usage of AI in mammography screening. 1 According to ...

Health’s latest survey reveals Americans give the nation’s healthcare system a low grade and are open to significant changes.

Fred Aslan, MD, CEO, Artiva Biotherapeutics, explains what the FDA Fast Track designation for AlloNK in autoimmune diseases means for the acceleration of its development and potential approval of the ...

Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ...

The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...

Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales ...

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are ...